Loading...
XKRX
192820
Market cap1.31bUSD
Jul 10, Last price  
172,700.00KRW
1D
-0.46%
1Q
-7.50%
Jan 2017
44.52%
IPO
123.70%
Name

Cosmax Inc

Chart & Performance

D1W1MN
XKRX:192820 chart
P/E
15.92
P/S
0.82
EPS
10,846.80
Div Yield, %
Shrs. gr., 5y
2.11%
Rev. gr., 5y
11.65%
Revenues
2.40t
+10.74%
336,230,290,990533,342,717,780756,963,565,000883,950,013,5701,259,716,816,0601,330,652,928,9701,382,880,688,5201,591,487,621,5001,600,125,770,1901,777,494,448,3202,166,089,637,0002,398,757,973,000
Net income
123.06b
+43.44%
16,605,447,82021,243,854,22034,781,930,68018,855,174,65032,621,456,32018,319,679,110-29,053,381,42034,336,481,890-16,446,826,86057,137,182,68085,796,824,000123,064,158,000
CFO
86.70b
+18.83%
1,169,690,940-6,503,440,45023,468,728,140-6,616,556,840-54,592,032,65074,567,223,71041,459,691,390100,045,547,950102,531,468,480231,020,761,95072,966,186,00086,704,662,000
Dividend
Dec 27, 2023500 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Cosmax, Inc. operates as a global entity engaged in the research, development, manufacturing, and distribution of a broad spectrum of goods, including cosmetic items, nutritional supplements, and pharmaceutical products. Its comprehensive beauty product line features skincare formulations, decorative makeup, hair care essentials, and specialty treatments such as facial masks and under-eye patches. Beyond its cosmetic offerings, the company also develops and produces medical equipment and supplies, provides raw materials for cosmetic formulations, and manufactures advanced containers and filling packaging for cosmetics. Originally established as Miroto Korea, the company rebranded to Cosmax, Inc. in 1994. Founded in 1992, its primary corporate offices are located in Hwaseong, South Korea.
IPO date
Apr 07, 2014
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT